{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:44:35Z","timestamp":1790700275170,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["FONDECYT#1210940"],"award-info":[{"award-number":["FONDECYT#1210940"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Multiple sclerosis (MS) is an irreversible progressive CNS pathology characterized by the loss of myelin (i.e. demyelination). The lack of myelin is followed by a progressive neurodegeneration triggering symptoms as diverse as fatigue, motor, locomotor and sensory impairments and\/or bladder, cardiac and respiratory dysfunction. Even though there are more than fourteen approved treatments for reducing MS progression, there are still no cure for the disease. Thus, MS research is a very active field and therefore we count with different experimental animal models for studying mechanisms of demyelination and myelin repair, however, we still lack a preclinical MS model assembling demyelination mechanisms with relevant clinical-like signs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here, by inducing the simultaneous demyelination of both callosal and cerebellar white matter fibers by the double-site injection of lysolecithin (LPC), we were able to reproduce CNS demyelination, astrocyte recruitment and increases levels of proinflammatory cytokines levels along with motor, locomotor and urinary impairment, as well as cardiac and respiratory dysfunction, in the same animal model. Single site LPC-injections either in corpus callosum or cerebellum only, fails in to reproduce such a complete range of MS-like signs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We here report that the double-site LPC injections treatment evoke a complex MS-like mice model. We hope that this experimental approach will help to deepen our knowledge about the mechanisms of demyelinated diseases such as MS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40659-024-00529-7","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T03:11:22Z","timestamp":1721617882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A preclinical mice model of multiple sclerosis based on the toxin-induced double-site demyelination of callosal and cerebellar fibers"],"prefix":"10.1186","volume":"57","author":[{"given":"Sebasti\u00e1n","family":"Vejar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio S.","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Pulgar-Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinay C.","family":"Vicencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Polit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian A.","family":"Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"del Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Varas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4776-4492","authenticated-orcid":false,"given":"Fernando C.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"issue":"2","key":"529_CR1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/nau.24279","volume":"39","author":"W Akakpo","year":"2020","unstructured":"Akakpo W, Chartier-Kastler E, Joussain C, Denys P, Lubetzki C, Ph\u00e9 V. Outcomes of ileal conduit urinary diversion in patients with multiple sclerosis. Neurourol Urodyn. 2020;39(2):771\u20137. https:\/\/doi.org\/10.1002\/nau.24279.","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"529_CR2","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1097\/HJH.0000000000002067","volume":"37","author":"P Araos","year":"2019","unstructured":"Araos P, Prado C, Lozano M, Figueroa S, Espinoza A, Berger T, Mak TW, Jaisser F, Pacheco R, Michea L, Amador CA. Dendritic cells are crucial for cardiovascular remodeling and modulate neutrophil gelatinase-associated lipocalin expression upon mineralocorticoid receptor activation. J Hypertens. 2019;37(7):1482\u201392. https:\/\/doi.org\/10.1097\/HJH.0000000000002067.","journal-title":"J Hypertens"},{"key":"529_CR3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/bonekey.2015.101","volume":"4","author":"A Bonetto","year":"2015","unstructured":"Bonetto A, Andersson DC, Waning DL. Assessment of muscle mass and strength in mice. Bonekey Rep. 2015;4:732. https:\/\/doi.org\/10.1038\/bonekey.2015.101.","journal-title":"Bonekey Rep"},{"issue":"2","key":"529_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/ene.14557","volume":"28","author":"FBS Briggs","year":"2021","unstructured":"Briggs FBS, Hill E, Abboud H. The prevalence of hypertension in multiple sclerosis based on 37 million electronic health records from the United States. Eur J Neurol. 2021;28(2):558\u201366. https:\/\/doi.org\/10.1111\/ene.14557.","journal-title":"Eur J Neurol"},{"issue":"4","key":"529_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol. 2011;164(4):1079\u2013106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x.","journal-title":"Br J Pharmacol"},{"key":"529_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/B978-0-444-52001-2.00005-4","volume":"122","author":"G Criste","year":"2014","unstructured":"Criste G, Trapp B, Dutta R. Axonal loss in multiple sclerosis: causes and mechanisms. Handb Clin Neurol. 2014;122:101\u201313. https:\/\/doi.org\/10.1016\/B978-0-444-52001-2.00005-4.","journal-title":"Handb Clin Neurol"},{"issue":"7471","key":"529_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12647","volume":"502","author":"VA Deshmukh","year":"2013","unstructured":"Deshmukh VA, Tardif V, Lyssiotis CA, Green CC, Kerman B, Kim HJ, Padmanabhan K, Swoboda JG, Ahmad I, Kondo T, Gage FH, Theofilopoulos AN, Lawson BR, Schultz PG, Lairson LL. A regenerative approach to the treatment of multiple sclerosis. Nature. 2013;502(7471):327\u201332. https:\/\/doi.org\/10.1038\/nature12647.","journal-title":"Nature"},{"key":"529_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102992","volume":"69","author":"E D\u00edaz-Jara","year":"2024","unstructured":"D\u00edaz-Jara E, Pereyra K, Vicencio S, Olesen MA, Schwarz KG, Toledo C, D\u00edaz HS, Quintanilla RA, Del Rio R. Superoxide dismutase 2 deficiency is associated with enhanced central chemoreception in mice: implications for breathing regulation. Redox Biol. 2024;69: 102992. https:\/\/doi.org\/10.1016\/j.redox.2023.102992.","journal-title":"Redox Biol"},{"issue":"5","key":"529_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/pharmaceutics15051373","volume":"15","author":"SM Figueroa","year":"2023","unstructured":"Figueroa SM, Bertocchio J-P, Nakamura T, El-Moghrabi S, Jaisser F, Amador CA. The mineralocorticoid receptor on smooth muscle cells promotes tacrolimus-induced renal injury in mice. Pharmaceutics. 2023;15(5):1373. https:\/\/doi.org\/10.3390\/pharmaceutics15051373.","journal-title":"Pharmaceutics"},{"issue":"6","key":"529_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/s0361-9230(01)00765-1","volume":"57","author":"RJ Franklin","year":"2002","unstructured":"Franklin RJ. Remyelination of the demyelinated CNS: the case for and against transplantation of central, peripheral and olfactory glia. Brain Res Bull. 2002;57(6):827\u201332. https:\/\/doi.org\/10.1016\/s0361-9230(01)00765-1.","journal-title":"Brain Res Bull"},{"issue":"12","key":"529_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrn.2017.136","volume":"18","author":"RJM Franklin","year":"2017","unstructured":"Franklin RJM, Ffrench-Constant C. Regenerating CNS myelin\u2014from mechanisms to experimental medicines. Nat Rev Neurosci. 2017;18(12):753\u201369. https:\/\/doi.org\/10.1038\/nrn.2017.136.","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"529_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJM Franklin","year":"2008","unstructured":"Franklin RJM, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008;9(11):839\u201355. https:\/\/doi.org\/10.1038\/nrn2480.","journal-title":"Nat Rev Neurosci"},{"key":"529_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.995477","volume":"15","author":"M Gharagozloo","year":"2022","unstructured":"Gharagozloo M, Mace JW, Calabresi PA. Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis. Front Mol Neurosci. 2022;15: 995477. https:\/\/doi.org\/10.3389\/fnmol.2022.995477.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"529_CR14","doi-asserted-by":"publisher","first-page":"8518","DOI":"10.1038\/ncomms9518","volume":"6","author":"HOB Gautier","year":"2015","unstructured":"Gautier HOB, Evans KA, Volbracht K, James R, Sitnikov S, Lundgaard I, James F, Lao-Peregrin C, Reynolds R, Franklin RJM, K\u00e1rad\u00f3ttir RT. Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors. Nat Commun. 2015;6(1):8518. https:\/\/doi.org\/10.1038\/ncomms9518.","journal-title":"Nat Commun"},{"issue":"2","key":"529_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3906\/sag-1912-6","volume":"50","author":"S G\u00f6kaslan","year":"2020","unstructured":"G\u00f6kaslan S, Demirba\u015f H, \u00d6zer G\u00f6kaslan \u00c7. Evaluation of cardiovascular autonomic dysfunction according to heart rate turbulence and variability in patients with relapsing remitting multiple sclerosis. Turk J Med Sci. 2020;50(2):442\u20137. https:\/\/doi.org\/10.3906\/sag-1912-6.","journal-title":"Turk J Med Sci"},{"key":"529_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.644797","volume":"8","author":"A Guerrero","year":"2021","unstructured":"Guerrero A, Visniauskas B, C\u00e1rdenas P, Figueroa SM, Vivanco J, Salinas-Parra N, Araos P, Nguyen QM, Kassan M, Amador CA, Prieto MC, Gonzalez AA. \u03b1-Ketoglutarate upregulates collecting duct (pro)renin receptor expression, tubular angiotensin II formation, and Na+ reabsorption during high glucose conditions. Front Cardiovasc Med. 2021;8: 644797. https:\/\/doi.org\/10.3389\/fcvm.2021.644797.","journal-title":"Front Cardiovasc Med"},{"key":"529_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-51892-7.00001-2","volume-title":"Handbook of clinical neurology","author":"DE Haines","year":"2012","unstructured":"Haines DE, Dietrichs E. The cerebellum\u2014structure and connections. In: Subramony SH, D\u00fcrr A, editors. Handbook of clinical neurology, vol. 103. Amsterdam: Elsevier; 2012. https:\/\/doi.org\/10.1016\/B978-0-444-51892-7.00001-2."},{"issue":"2","key":"529_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1242\/jcs.10.2.535","volume":"10","author":"SM Hall","year":"1972","unstructured":"Hall SM. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci. 1972;10(2):535\u201346. https:\/\/doi.org\/10.1242\/jcs.10.2.535.","journal-title":"J Cell Sci"},{"issue":"4","key":"529_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41582-022-00624-x","volume":"18","author":"LM Healy","year":"2022","unstructured":"Healy LM, Stratton JA, Kuhlmann T, Antel J. The role of glial cells in multiple sclerosis disease progression. Nat Rev Neurol. 2022;18(4):237\u201348. https:\/\/doi.org\/10.1038\/s41582-022-00624-x.","journal-title":"Nat Rev Neurol"},{"key":"529_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-802395-2.00019-5","volume":"145","author":"R H\u00f6ftberger","year":"2018","unstructured":"H\u00f6ftberger R, Lassmann H. Inflammatory demyelinating diseases of the central nervous system. Handb Clin Neurol. 2018;145:263\u201383. https:\/\/doi.org\/10.1016\/B978-0-12-802395-2.00019-5.","journal-title":"Handb Clin Neurol"},{"issue":"7393","key":"529_CR21","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nature11108","volume":"484","author":"C Humphries","year":"2012","unstructured":"Humphries C. Progressive multiple sclerosis: the treatment gap. Nature. 2012;484(7393):S10. https:\/\/doi.org\/10.1038\/nature11108.","journal-title":"Nature"},{"key":"529_CR22","doi-asserted-by":"publisher","first-page":"52679","DOI":"10.3791\/52679","volume":"97","author":"MB Keough","year":"2015","unstructured":"Keough MB, Jensen SK, Yong VW. Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin. J Vis Exp. 2015;97:52679. https:\/\/doi.org\/10.3791\/52679.","journal-title":"J Vis Exp"},{"issue":"1306","key":"529_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2009.09.103","volume":"8","author":"ST Kim","year":"2010","unstructured":"Kim ST, Son HJ, Choi JH, Ji IJ, Hwang O. Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson\u2019s disease. Brain Res. 2010;8(1306):176\u201383. https:\/\/doi.org\/10.1016\/j.brainres.2009.09.103.","journal-title":"Brain Res"},{"issue":"3","key":"529_CR24","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/ijms25031445","volume":"25","author":"M Kipp","year":"2024","unstructured":"Kipp M. How to use the cuprizone model to study de- and remyelination. Int J Mol Sci. 2024;25(3):1445. https:\/\/doi.org\/10.3390\/ijms25031445.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"529_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jneumeth.2011.10.001","volume":"203","author":"SM Klein","year":"2012","unstructured":"Klein SM, Vykoukal J, Lechler P, Zeitler K, Gehmert S, Schreml S, Alt E, Bogdahn U, Prantl L. Noninvasive in vivo assessment of muscle impairment in the mdx mouse model\u2014a comparison of two common wire hanging methods with two different results. J Neurosci Methods. 2012;203(2):292\u20137. https:\/\/doi.org\/10.1016\/j.jneumeth.2011.10.001.","journal-title":"J Neurosci Methods"},{"issue":"1","key":"529_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, Marrie RA, Montalban X, Yong VW, Thompson AJ, Reich DS. Multiple sclerosis progression: time for a new mechanism-driven framework. International Advisory Committee on Clinical Trials in Multiple Sclerosis. Lancet Neurol. 2023;22(1):78\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(22)00289-7.","journal-title":"Lancet Neurol"},{"issue":"2","key":"529_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","volume":"133","author":"H Lassmann","year":"2017","unstructured":"Lassmann H, Bradl M. Multiple sclerosis: experimental models and reality. Acta Neuropathol. 2017;133(2):223\u201344. https:\/\/doi.org\/10.1007\/s00401-016-1631-4.","journal-title":"Acta Neuropathol"},{"issue":"19","key":"529_CR28","doi-asserted-by":"publisher","first-page":"11342","DOI":"10.3390\/ijms231911342","volume":"23","author":"C Lubrich","year":"2022","unstructured":"Lubrich C, Giesler P, Kipp M. Motor behavioral deficits in the cuprizone model: validity of the Rotarod test paradigm. Int J Mol Sci. 2022;23(19):11342. https:\/\/doi.org\/10.3390\/ijms231911342.","journal-title":"Int J Mol Sci"},{"key":"529_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11061146","author":"PP Maldonado","year":"2022","unstructured":"Maldonado PP, Guevara C, Olesen MA, Orellana JA, Quintanilla RA, Ortiz FC. Neurodegeneration in multiple sclerosis: the role of Nrf2-dependent pathways. Antioxidants. 2022. https:\/\/doi.org\/10.3390\/antiox11061146.","journal-title":"Antioxidants"},{"issue":"8","key":"529_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and treatment of multiple sclerosis: a review. JAMA. 2021;325(8):765\u201379. https:\/\/doi.org\/10.1001\/jama.2020.26858.","journal-title":"JAMA"},{"issue":"7321","key":"529_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature09614","volume":"468","author":"K-A Nave","year":"2010","unstructured":"Nave K-A. Myelination and support of axonal integrity by glia. Nature. 2010;468(7321):244\u201352. https:\/\/doi.org\/10.1038\/nature09614.","journal-title":"Nature"},{"key":"529_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123434","volume":"5","author":"FC Ortiz","year":"2019","unstructured":"Ortiz FC, Habermacher C, Graciarena M, Houry P-Y, Nishiyama A, Nait Oumesmar B, Angulo MC. Neuronal activity in vivo enhances functional myelin repair. JCI Insight. 2019;5: 123434. https:\/\/doi.org\/10.1172\/jci.insight.123434.","journal-title":"JCI Insight"},{"key":"529_CR33","doi-asserted-by":"publisher","first-page":"1207007","DOI":"10.3389\/fnmol.2023.1207007","volume":"16","author":"D Packer","year":"2023","unstructured":"Packer D, Fresenko EE, Harrington EP. Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration. Front Mol Neurosci. 2023;16:1207007. https:\/\/doi.org\/10.3389\/fnmol.2023.1207007.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"529_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/glia.23245","volume":"66","author":"JR Plemel","year":"2017","unstructured":"Plemel JR, Michaels NJ, Weishaupt N, Caprariello AV, Keough MB, Rogers JA, Yukseloglu A, Lim J, Patel VV, Rawji KS, Jensen SK, Teo W, Heyne B, Whitehead SN, Stys PK, Yong VW. Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy. Glia. 2017;66(2):327\u201347. https:\/\/doi.org\/10.1002\/glia.23245.","journal-title":"Glia"},{"issue":"4","key":"529_CR35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/nau.24649","volume":"40","author":"R Ramasamy","year":"2021","unstructured":"Ramasamy R, Smith PP. Animal modeling of lower urinary tract dysfunction associated with multiple sclerosis: Part I: justification of the mouse model for MS research. Neurourol Urodyn. 2021;40(4):950\u20137. https:\/\/doi.org\/10.1002\/nau.24649.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"529_CR36","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/nau.24654","volume":"40","author":"R Ramasamy","year":"2021","unstructured":"Ramasamy R, Smith PP. PART 2: mouse models for multiple sclerosis research. Neurourol Urodyn. 2021;40(4):958\u201367. https:\/\/doi.org\/10.1002\/nau.24654.","journal-title":"Neurourol Urodyn"},{"key":"529_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fncel.2015.00077","volume":"9","author":"A Sahel","year":"2015","unstructured":"Sahel A, Ortiz FC, Kerninon C, Maldonado PP, Angulo MC, Nait-Oumesmar B. Alteration of synaptic connectivity of oligodendrocyte precursor cells following demyelination. Front Cell Neurosci. 2015;9:77. https:\/\/doi.org\/10.3389\/fncel.2015.00077.","journal-title":"Front Cell Neurosci"},{"issue":"7631","key":"529_CR38","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/540S2a","volume":"540","author":"C Schmidt","year":"2016","unstructured":"Schmidt C. Biology: a degenerative affliction. Nature. 2016;540(7631):S2\u20133. https:\/\/doi.org\/10.1038\/540S2a.","journal-title":"Nature"},{"issue":"1","key":"529_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12915-023-01679-y","volume":"21","author":"H-M Shan","year":"2023","unstructured":"Shan H-M, Maurer MA, Schwab ME. Four-parameter analysis in modified Rotarod test for detecting minor motor deficits in mice. BMC Biol. 2023;21(1):177. https:\/\/doi.org\/10.1186\/s12915-023-01679-y.","journal-title":"BMC Biol"},{"issue":"8","key":"529_CR40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/glia.20815","volume":"57","author":"AM Sheikh","year":"2009","unstructured":"Sheikh AM, Nagai A, Ryu JK, McLarnon JG, Kim SU, Masuda J. Lysophosphatidylcholine induces glial cell activation: role of rho kinase. Glia. 2009;57(8):898\u2013907. https:\/\/doi.org\/10.1002\/glia.20815.","journal-title":"Glia"},{"issue":"1","key":"529_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","volume":"31","author":"BD Trapp","year":"2008","unstructured":"Trapp BD, Nave K-A. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci. 2008;31(1):247\u201369. https:\/\/doi.org\/10.1146\/annurev.neuro.30.051606.094313.","journal-title":"Annu Rev Neurosci"},{"issue":"5","key":"529_CR42","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2174\/187152712801661284","volume":"11","author":"BJ van der Star","year":"2012","unstructured":"van der Star BJ, Vogel DYS, Kipp M, Puentes F, Baker D, Amor S. In vitro and in vivo models of multiple sclerosis. CNS Neurol Disord Drug Targets. 2012;11(5):570\u201388. https:\/\/doi.org\/10.2174\/187152712801661284.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"45","key":"529_CR43","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.2174\/1381612825666191216125725","volume":"25","author":"R Varas","year":"2019","unstructured":"Varas R, Ortiz FC. Neuroinflammation in demyelinating diseases: oxidative stress as a modulator of glial cross-talk. Curr Pharm Des. 2019;25(45):4755\u201362. https:\/\/doi.org\/10.2174\/1381612825666191216125725.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"529_CR44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.23736\/S1973-9087.22.07217-3","volume":"58","author":"M Vecchio","year":"2022","unstructured":"Vecchio M, Chiaramonte R, Di Benedetto P. Management of bladder dysfunction in multiple sclerosis: a systematic review and meta-analysis of studies regarding bladder rehabilitation. Eur J Phys Rehabil Med. 2022;58(3):387\u201396. https:\/\/doi.org\/10.23736\/S1973-9087.22.07217-3.","journal-title":"Eur J Phys Rehabil Med"},{"issue":"3","key":"529_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(sici)1098-1136(19990201)25:3<216::aid-glia2>3.0.co;2-l","volume":"25","author":"RH Woodruff","year":"1999","unstructured":"Woodruff RH, Franklin RJ. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement\/anti-galactocerebroside: a comparative study. Glia. 1999;25(3):216\u201328. https:\/\/doi.org\/10.1002\/(sici)1098-1136(19990201)25:3%3c216::aid-glia2%3e3.0.co;2-l.","journal-title":"Glia"},{"issue":"1","key":"529_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12974-022-02557-0","volume":"19","author":"Y Xie","year":"2022","unstructured":"Xie Y, Chen X, Li Y, Chen S, Liu S, Yu Z, Wang W. Transforming growth factor-\u03b21 protects against LPC-induced cognitive deficit by attenuating pyroptosis of microglia via NF-\u03baB\/ERK1\/2 pathways. J Neuroinflamm. 2022;19(1):194. https:\/\/doi.org\/10.1186\/s12974-022-02557-0.","journal-title":"J Neuroinflamm"},{"issue":"6","key":"529_CR47","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/jnc.15142","volume":"156","author":"R Yamazaki","year":"2021","unstructured":"Yamazaki R, Ohno N, Huang JK. Acute motor deficit and subsequent remyelination-associated recovery following internal capsule demyelination in mice. J Neurochem. 2021;156(6):917\u201328. https:\/\/doi.org\/10.1111\/jnc.15142.","journal-title":"J Neurochem"},{"key":"529_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2023.105505","volume":"164","author":"R Yamazaki","year":"2023","unstructured":"Yamazaki R, Osanai Y, Kouki T, Huang JK, Ohno N. Pharmacological treatment promoting remyelination enhances motor function after internal capsule demyelination in mice. Neurochem Int. 2023;164: 105505. https:\/\/doi.org\/10.1016\/j.neuint.2023.105505.","journal-title":"Neurochem Int"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-024-00529-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-024-00529-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-024-00529-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T03:14:35Z","timestamp":1721618075000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-024-00529-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1186\/s40659-024-00529-7","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors have nothing to competing interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}